Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Multiplex ddPCR assay for screening copy number variations in BRCA1 gene. / Oscorbin, Igor; Kechin, Andrey; Boyarskikh, Uljana и др.
в: Breast Cancer Research and Treatment, Том 178, № 3, 01.12.2019, стр. 545-555.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Multiplex ddPCR assay for screening copy number variations in BRCA1 gene
AU - Oscorbin, Igor
AU - Kechin, Andrey
AU - Boyarskikh, Uljana
AU - Filipenko, Maxim
PY - 2019/12/1
Y1 - 2019/12/1
N2 - Purpose: Germinal and somatic rearrangements in BRCA1 gene play a significant role in carcinogenesis of breast and ovarian cancer. The present study is dedicated to the development of multiplex droplet digital PCR (ddPCR) assay for detecting large deletions and duplications in the BRCA1 gene. Methods: In-house tetraplex ddPCR assay for BRCA1 gene analysis was used for testing of DNA samples with BRCA1 status. Results: DNA specimens were purified from 24 individuals. The presence of BRCA1 rearrangements in samples was confirmed by a commercial MLPA-based kit. An amplitude-based multiplex ddPCR assay was developed: 8 multiplexes, each containing primers and probes to amplify 3 BRCA1 exons and 1 reference gene (ALB or RPP30). A novel assay demonstrated 100% concordance with the commercial MLPA-based kit, identifying 9 specimens with different deletions in BRCA1, 1 with duplication, and 14 with the wild-type BRCA1. Conclusions: We have designed a simple, precise, and cost-effective assay for BRCA1 rearrangement testing, based on ddPCR. The developed assay is the first multiplex ddPCR-based test that provides results in accordance with MLPA and can be used for routine clinical screening.
AB - Purpose: Germinal and somatic rearrangements in BRCA1 gene play a significant role in carcinogenesis of breast and ovarian cancer. The present study is dedicated to the development of multiplex droplet digital PCR (ddPCR) assay for detecting large deletions and duplications in the BRCA1 gene. Methods: In-house tetraplex ddPCR assay for BRCA1 gene analysis was used for testing of DNA samples with BRCA1 status. Results: DNA specimens were purified from 24 individuals. The presence of BRCA1 rearrangements in samples was confirmed by a commercial MLPA-based kit. An amplitude-based multiplex ddPCR assay was developed: 8 multiplexes, each containing primers and probes to amplify 3 BRCA1 exons and 1 reference gene (ALB or RPP30). A novel assay demonstrated 100% concordance with the commercial MLPA-based kit, identifying 9 specimens with different deletions in BRCA1, 1 with duplication, and 14 with the wild-type BRCA1. Conclusions: We have designed a simple, precise, and cost-effective assay for BRCA1 rearrangement testing, based on ddPCR. The developed assay is the first multiplex ddPCR-based test that provides results in accordance with MLPA and can be used for routine clinical screening.
KW - BRCA1
KW - CNV
KW - Digital PCR
KW - Gene rearrangements
KW - Multiplex amplification
UR - http://www.scopus.com/inward/record.url?scp=85071724862&partnerID=8YFLogxK
U2 - 10.1007/s10549-019-05425-3
DO - 10.1007/s10549-019-05425-3
M3 - Article
C2 - 31482362
AN - SCOPUS:85071724862
VL - 178
SP - 545
EP - 555
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
SN - 0167-6806
IS - 3
ER -
ID: 21451327